Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Dermavant’s Vtama Appears Well Positioned To Compete With Other Topicals In AD
Mar 15 2023
•
By
Joseph Haas
Dermavant is working toward adding atopic dermatitis to Vtama's label • Source: Shutterstock
More from Strategy
More from Business